首页 | 本学科首页   官方微博 | 高级检索  
     


Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: an analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)
Authors:McMurray John J V  Uno Hajime  Jarolim Petr  Desai Akshay S  de Zeeuw Dick  Eckardt Kai-Uwe  Ivanovich Peter  Levey Andrew S  Lewis Eldrin F  McGill Janet B  Parfrey Patrick  Parving Hans-Henrik  Toto Robert M  Solomon Scott D  Pfeffer Marc A
Affiliation:aBHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom;bBrigham and Women's Hospital, Boston, MA;cDepartment of Biostatistics, Harvard School of Public Health, Boston, MA;dDepartment of Clinical Pharmacology, University Medical Center, and University of Gronigen, Groningen, The Netherlands;eDepartment of Nephrology and Hypertension, University of Erlangen-Nuremberg, Erlangen, Germany;fDivision of Nephrology and Hypertension, Northwestern University Feinberg School of Medicine Chicago, Chicago, IL;gDivision of Nephrology, Tufts Medical Center, Boston, MA;hDivision of Endocrinology, Metabolism and Lipid Research, Washington University in St Louis, St Louis, MO;iDivision of Nephrology, Health Sciences Center, St John's, Newfoundland, Canada;jDepartment of Medical Endocrinology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark;kDepartment of Medicine, University of Texas Southwestern Medical Center, Dallas, TX
Abstract:
Keywords:
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号